Actively Recruiting
Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-06-01
600
Participants Needed
17
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on people with primary lung cancer who are undergoing planned pulmonary segmentectomy, a surgical procedure to remove part of the lung. The study aims to collect real-world data on patients with clinical Stage I lung cancer, assessing their outcomes over time to better understand disease progression and recovery. The research is conducted by Memorial Sloan Kettering Cancer Center and involves an international registry to gather comprehensive information about this patient group. Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and again 6 months after surgery. The study collects patient-reported outcomes using the Patient-Reported Outcomes Measurement Information System (PROMIS), which evaluates physical function, pain interference, and shortness of breath. This setup helps researchers understand patients' experiences and recovery in a structured way. Throughout the study, researchers will track disease-free survival at both 3 years and 5 years after surgery to measure longer-term outcomes. Participants will provide information through surveys administered at scheduled times, and their health status will be monitored without affecting their usual medical care. The total participation duration extends over several years as outcomes are followed up to 5 years post-surgery to understand the effectiveness of pulmonary segmentectomy in real-world conditions.
CONDITIONS
Brief Title
A Registry for People With Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Clinical Stage I with suspected non-small cell lung cancer (NSCLC) based on preoperative classification
- Pathologic diagnosis of NSCLC may be confirmed before, during, or after surgery
You will not qualify if you...
- Currently receiving lung cancer treatment or history of lung cancer within the past 5 years
- History of chemotherapy or radiation therapy for previous lung cancer
- Presence of synchronous secondary cancer in the lung or elsewhere at time of surgery
- Diagnosis of carcinoid tumors
- History of other malignancies within past 3 years except non-melanoma skin cancer, superficial bladder cancer, or carcinoma in situ of the cervix
- Actively receiving treatment for other malignancies
- Cases involving lobectomy combined with segmentectomy from another lobe or two or more segmentectomies from different lobes are excluded from primary analysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to hospital discharge
Participants undergo planned pulmonary segmentectomy for primary lung cancer and receive immediate post-operative care.
1 hospitalization period for surgery and immediate recovery
Duration - Up to 5 years
Participants are observed over several years to assess disease-free survival and patient-reported outcomes using the PROMIS system.
Periodic assessments over 3 to 5 years including patient-reported outcomes surveys
Trial Site Locations
Total: 17 locations
1
University of Arizona (Data Collection Only)
Tucson, Arizona, United States, 85704
Actively Recruiting
2
Rush University Medical Center (Data collection only)
Chicago, Illinois, United States, 606012
Actively Recruiting
3
Endeavor Health
Evanston, Illinois, United States, 60201
Actively Recruiting
4
University of Michigan (Data Collection Only)
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
5
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, United States, 07920
Actively Recruiting
6
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, United States, 07748
Actively Recruiting
7
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, United States, 07645
Actively Recruiting
8
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
Commack, New York, United States, 11725
Actively Recruiting
9
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, United States, 10604
Actively Recruiting
10
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065
Actively Recruiting
11
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, New York, United States, 11553
Actively Recruiting
12
Thomas Jefferson University Hospital (Data Collection Only)
Philadelphia, Pennsylvania, United States, 19107
Actively Recruiting
13
ALLEGHENY HEALTH NETWORK (Data Collection Only)
Pittsburgh, Pennsylvania, United States, 15212
Actively Recruiting
14
Baylor University Medical Center (Data Collection Only)
Dallas, Texas, United States, 75246
Actively Recruiting
15
MD Anderson Cancer Center (Data Collection Only)
Houston, Texas, United States, 77030
Actively Recruiting
16
University Health Network (Data Collection Only)
Toronto, Ontario, Canada, M5G 2C4
Actively Recruiting
17
Centre Hospitalier de l'Université de Montreal (Data Collection Only)
Montreal, Quebec, Canada, H2L 4M1
Actively Recruiting
Research Team
D
David Jones, MD
B
Bernard Park, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here